Market Overview

OvaScience to Launch New Potential Fertility Treatment OvaPrime in 2015

OvaScienceSM, (NASDAQ: OVAS) today provided an update on its product pipeline and
commercial plans, which are based on its egg precursor cell (EggPCSM)
technology platform. OvaScience expects to commercialize AUGMENTSM
in international in vitro fertilization (IVF) clinics in 2014 and
to launch its newest potential fertility treatment, OvaPrimeSM,
in 2015.

See full press release

Posted-In: News Guidance Management Global

 

Related Articles (OVAS)

Around the Web, We're Loving...

Get Benzinga's Newsletters